"pancreatic" in Spanish

The evidence for esophageal, gastric, colon, rectum, and pancreatic cancer was conflicting.

Pancreatic cancer is a leading cause of cancer death.

Primary outcomes were mortality and pancreatic infection rates.

There was limited moderate to strong evidence for lung, pancreatic and colorectal cancer.

Pancreatic necrosis may complicate severe acute pancreatitis, and is detectable by computed tomography (CT).

In a subgroup with pancreatic insufficiency malabsorption of the fat soluble vitamins (A, D, E, K) may occur.

A previous version published in 2006 suggested a survival advantage overall, and a decrease in pancreatic infections for some types of antibiotic therapy (beta-lactam antibiotics).

Imipenem on its own showed no difference in the incidence of mortality, but there was a significant reduction in the rate of pancreatic infection (p=0.02;

Cystic fibrosis with pancreatic insufficiency can cause vitamins, such as vitamin D, to be inadequately absorbed leading to vitamin deficiencies.

Secondary end-points included non pancreatic infection, all sites infection, operative rates, fungal infections, and antibiotic resistance.

If severe, the pancreas may lose its blood supply, a complication called pancreatic necrosis that can be detected by computed tomography (CT) scanning.

Non-pancreatic infection rates and the incidence of overall infections were not significantly reduced with antibiotics: 23.7% versus 36%; 37.5% versus 51.9% respectively.